Prevalence of Human Immunodeficiency Virus and Opportunistic Infections Among Transgender Patients in the Clinical Setting: An All-Payer Electronic Health Record Database Study.
Joshua D Niforatos, Jonathon W Wanta, Emily Durbak, Jacqueline Cavendish, Justin A Yax
Author Information
Joshua D Niforatos: Department of Emergency Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Jonathon W Wanta: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.
Emily Durbak: Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA.
Jacqueline Cavendish: Division of Population Health, Department of Emergency Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Justin A Yax: Division of Population Health, Department of Emergency Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
We performed a cross-sectional analysis of the prevalence of HIV and Opportunistic Infections among transgender patients in clinical care. Of 10,160 transgender patients identified, 3.9% had a diagnosis of HIV, compared to 0.32% in the non-transgender cohort (<0.0001). Transgender patients experience the burden of all opportunistic infection compared to non-transgender patients in this analysis, although prevalence of pneumocystis pneumonia was not significant. This cohort-based, all-payer electronic health record study of HIVpatients connected to care revealed that transgender patients have a higher prevalence of HIV infection and Opportunistic Infections compared to the non-transgender cohort.
